Second Lawsuit from Pfizer to Novo Nordisk!

Pfizer, Novo Nordisk, and the biotechnology company Metsera have filed a second lawsuit against each other. This lawsuit has been presented in an effort to block Novo Nordisk's acquisition of Metsera. By initiating this legal action, Pfizer claims that actions are being taken against competition in the biotechnology sector.

Such legal proceedings in the biotechnology market stand out as developments that investors need to monitor closely. Pfizer's move could change the dynamics in the sector and affect market trends.